Page 57 - Aneesh Phadnis

Pricing pressure in US will continue: CEO GlaxoSmithKline Plc

British drug maker GSK's global CEO Sir Andrew Witty will step down next March after eight years

SRL Diagnostics steps up expansion, eyes 10% revenue from overseas

SRL Diagnostics plans to set up five overseas laboratories in the next six months with special focus on the African region

Cartelisation probe against Dr Reddy's, Sun Pharma in US

Pharma stocks tumble 4% on BSE; Sun Pharma down 7.4%, Dr Reddy's loses 5.6%

Pharma stocks under pressure on US anti-trust probe

Suspense over US election result also weighs on market as stocks fall 3-7 percent

Jet Airways to consult pilots' union on duty hours

Last month, the airline introduced a new software to optimise duty rosters of pilots on trial basis

US travel advisory will not hit arrivals: Tour operators

Inbound tourism is expected to grow 10 per cent this year with strong growth from Asian markets

Pharma firms divided on drug trial proposal

Some allege that the move to amend the validity period is being taken up at the behest of multinational drug cos

Chandilya, other former executives under scanner in AirAsia probe

Chandilya was the first CEO of the company and resigned in March after his contract was not renewed

Jet Airways expands code share pact with Delta, Virgin Atlantic

Codeshare with United will be discontinued from the start of the summer 2017 schedule

Jet Airways' code sharing pact to enhance connectivity between US and India

Jet customers flying to North America will be able to connect to nine US destinations operated by Delta

Navi Mumbai airport take-off on stand-by till May 2020

Bidders find construction time frame unrealistic

Glenmark aims for substantial debt reduction in FY 17

The firm is expecting a strong growth in its US business in the second half of the year.

GMR wins $270 million arbitration award in Maldives airport dispute

The award followed a ruling in February which upheld GMR's case, on cancellation of an airport development contract there by the Maldives govt in November 2012

Ratan Tata piloted group's foray in aviation, Mistry says he had no say in the decision

Both the decisions occurred within a year of Cyrus Mistry taking over as group chairperson but now as Mistry's email to Tata Sons board members indicates he might have had little role in them.

I had no say in aviation foray: Mistry

In his letter, Mistry points out negotiations with both AirAsia and Singapore Airlines were carried out by Ratan Tata

Drug companies step up global investments to tap biosimilars

Cipla is investing Rs 600 crore to set up a manufacturing plant for biosimilars in South Africa

Pharma companies increase investments for global biosimilar push

Biosimilars are made from living cells and are far more complex and expensive to manufacture than generic drugs

Ibibo deal is strategic, not for reducing losses, says MakeMyTrip India CEO

Interview with Co-founder and India CEO, MakeMyTrip

MakeMyTrip-ibibo deal: Consolidation in travel space gathers tailwind

In wake of MakeMyTrip-ibibo deal, customers could benefit from better offerings and firms in segment could expect some relief from hyper-competition

MakeMyTrip boards ibibo, to lead market

Buyer's shares soar 54% to $31.4 on Nasdaq